drugset / Trial / NCT03321292

L-arginine in Treatment of Intrauterine Growth Restriction

NCT03321292

Unknown 260 enrolled Ain Shams University
RandomizedParallel-groupSingle-blindTreatment

Summary

Intrauterine growth restriction is an important problem in neonatal care. Intrauterine growth restriction (IUGR) is defined as a fetal weight below the 10th percentile for gestational age. One of the main causes of IUGR is placental insufficiency. Nitric oxide(NO) increases placental blood flow. So,it might be useful to improve IUGR pregnancy outcome .

Timeline

Start
2017-10-15
Primary completion
2018-12-01
Completion
2018-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject L-arginine Small molecule 1000 mg Oral
Comparator Aspirin Small molecule 75 mg Oral